Current Report Filing (8-k)
March 20 2017 - 8:46AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
March 20, 2017
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
333-192989
|
|
22-3832302
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
7.01
|
Regulation
FD Disclosure.
|
The
Registrant is hereby furnishing the following information under Regulation FD:
On
March 20, 2017, the Registrant issued a press release announcing that its Board of Directors has declared monthly cash dividends
for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”) for March through
May 2017.
A
copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Safe
Harbor Statement
Statements
contained in the exhibit to report that state the Company’s or its management’s expectations or predictions of the
future are forward-looking statements intended to be covered by the safe harbor provisions of the Securities Act of 1933, as amended,
and the Securities Exchange Act of 1934, as amended. It is important to note that the Company’s actual results could differ
materially from those projected in such forward-looking statements. The Company does not assume any obligations to update the
forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were
made.
Item
9.01
|
Financial
Statements and Exhibits
|
Exhibit
No.
|
|
Description
|
|
|
|
99.1
|
|
Press
Release issued March 20, 2017 by Medical Transcription Billing, Corp.
|
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical
Transcription Billing, Corp.
|
|
|
Date:
March 20, 2017
|
By:
|
/s/
Mahmud Haq
|
|
|
Mahmud
Haq
|
|
|
Chairman
of the Board and Chief Executive Officer
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jun 2024 to Jul 2024
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jul 2023 to Jul 2024